Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: CRM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on CRM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 502,872 CRM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 502,872 shares
    Change vs previous 13F +43,826 shares

    1.44% of the 13F portfolio, value $78,779,928.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 459,046 shares
    Change vs previous 13F +114,010 shares

    1.65% of the 13F portfolio, value $85,690,117.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 345,036 shares
    Change vs previous 13F +219,597 shares

    1.92% of the 13F portfolio, value $91,410,340.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 125,439 shares
    Change vs previous 13F -35,473 shares

    0.67% of the 13F portfolio, value $29,731,286.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 160,912 shares
    Change vs previous 13F +75,859 shares

    1.36% of the 13F portfolio, value $43,882,441.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 85,053 shares
    Change vs previous 13F -44,274 shares

    0.71% of the 13F portfolio, value $22,826,654.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 129,327 shares
    Change vs previous 13F not available

    1.5% of the 13F portfolio, value $43,241,388.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).